HBV and HCV

Commentaries

• Hiebert L* and Ward JW*. Strategic information to guide elimination of viral hepatitis. Lancet Gastro Hep.
• Valdiserri, R. O., Koh, H. K., and Ward, J. W*. Overcome Health Inequities to Eliminate Viral Hepatitis. JAMA.
• Ghaffar, K. A., Ward, J. W.*, Ali, N.*, & Hassany, M. Launch of the UN Group of Friends to eliminate hepatitis. Lancet Gastro Hep.
• El-Serag, H. B., Ward, J. W.*, Asrani, S. K., Singal, A. G., Rich, N., Thrift, A. P., Deshpande, S., Turner, B. J., Kaseb, A. O., Harrison, A. C., Fortune, B. E., & Kanwal, F. Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference. Clinical Gastroenterology and Hepatology Journal.

HBV

Commentaries

• Njuguna, H. N.*, Hiebert, L.*, Gupta, N.*, & Ward, J. W*. Status of HBV Birth Dose Vaccination in Africa: The Impact of COVID-19 and Gavi Support on Policy Development. Lancet Gastro Hep.

HCV

Abstracts

• Neil Gupta*, Lindsey Hiebert*, Ankeeta Saseetharran*, Catherine Chappell, Manal El-Sayed, Ravi Jhaveri, Ali Judd, Tatyana Kushner, Carolyn Wester, John Ward*. Direct-Acting Antiviral Exposure in Pregnancy: Initial Findings from the “Tip-HepC” Clinical Case Registry. GHS 2023. 

HBV

Research Studies

• GBD 2019 Hepatitis B Collaborators: Sheena BS, Hiebert L*, Han H, Ippolito H, ... Ward JW*, Dirac MA.  Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastro Hep.
• Nartey, Y. A.*, Okine, R., Seake-Kwawu, A., Ghartey, G., Asamoah, Y. K., Senya, K., Duah, A., Owusu-Ofori, A., Amugsi, J., Suglo, D., Bampoh, S. A., Hiebert, L.*, Njuguna, H.*, Ward, J. W.*, Plymoth, A., Roberts, L. R., Bockarie, A. S., Awuku, Y. A., & Obiri-Yeboah, D. A Nationwide Cross-Sectional Review of In-Hospital Hepatitis B Virus Testing and Disease Burden Estimation in Ghana, 2016 - 2021. BMC Public Health.

Abstracts

• Osiowy C, Gravel G, Lourenco L, Thompson LH, O'Brien S, Bink M, Hiebert L*, Coffin CS. Assessing Progress Towards Hepatitis B (HepB) Elimination In Canada. IVHEM 2022.
• Njuguna H*, Jacques-Carroll*, Hiebert L*, Gupta N*, Kabore J, Ward JW*, Tohme R. Introducing Hepatitis B Birth Dose (HepB-BD) Vaccination in Africa: A Toolkit for National Immunization Technical Advisory Groups (NITAGs). COLDA 2022.
• Njuguna H*, Hiebert L*, Damian I, Adjei CA, Matemba M, Latamaguzi E, Kabagambe K, Bwambale A, Debes JD, Jacques-Carroll L*, Gupta N*, Tohme R, Ward JW*. Bridging Science and Policy: Civil Society Organizations (CSOs) Advocating for Hepatitis B Birth Dose (HepB-BD) Vaccine Introduction in Africa. COLDA 2022.
• Wong R, Brosgart C, Wong S, Feld J, Glenn J, Moraras K, Ward JW*, Wedemeyer H, Yurdaydin C, Gish R. Estimating the Prevalence of Hepatitis Delta Infection among Foreign-Born Adults with Chronic Hepatitis B in the United States. EASL ILC 2022.

HCV

Commentaries & Book Chapters

• Gupta N*, Hiebert L*, Armstrong PA, Wester C, Ward JW*. Hepatitis C in pregnancy and the TiP-HepC registry. Lancet Gastro Hep.

Research Studies

• Cunningham EB, Wheeler A, Hajarizadeh B, French CE, Roche R, Marshall AD, Fontaine G, Conway A, Valencia BM, Bajis S, Presseau J, Ward JW*, Degenhardt L, Dore GJ, Hickman M, Vickerman P, Grebely J. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis.  Lancet Gastro Hep. 
• Lazarus JV, Picchio CA, Byrne CJ, Crespo J, Colombo M,  Cooke GS, Dore GJ, Gerbely J, Ward JW*, Dillon JF. A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination. Semin Liv Disease.

Abstracts

• Gupta N*, Hiebert L*, Armstrong P, Wester C, Ward JW*. Treatment Options for Hepatitis C in Pregnant Women: A Systematic Review of the Evidence and Future Research Needs. EASL ILC 202.

HBV and HCV

Research Studies

• Razeen MAH, Hiebert L*, Sugiyama A, Ouoba S, Bunthen E, Ko K, Akita T, Kaneko S, Kanto T, Ward JW,* Tanaka J.  Effect of COVID-19 on hepatitis B and C virus countermeasures: Hepatologist responses from nationwide survey in Japan. Hepatology Research.
• Tanaka J, Kurisu A, Ohara M, Ouoba S, Ohisa M, Sugiyama A, Wang ML, Hiebert L*, Kanto T, Akita T. Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: A simulation study. Lancet Regional Health Western Pacific. 
• Nartey YA, Antwi SO, Bockarie AS, Hiebert L*, Njuguna H*, Ward JW*, Awuku YA, Plymoth A, Roberts LR. Mortality burden due to liver cirrhosis and hepatocellular carcinoma in Ghana; prevalence of risk factors and predictors of poor in-hospital survival. PLoS One.

Abstracts

• Ali N*, Gupta N*, Ward JW*. The Potential of Viral Hepatitis Elimination Programs for Pandemic Preparedness and Response: A Scoping Review of COVID-19 and Viral Hepatitis Case Studies. IVHEM 2022.
• Desalegn H, Adugna W, Erike M, Gupta N*, Njuguna H*, Hiebert L*, Ward JW*. Where does Ethiopia stand on the journey to eliminate hepatitis B and C? An Assessment of the National Hepatitis Elimination Profile for Ethiopia. COLDA 2022.
• Hiebert L*, Nassar I-Y*, Nunez V*, Kondili L, Mandal S, Foster G, Garcia-Samaniego J, Bruggman P, Bonanni P, Picchio CA, Marinho R, Lazarus JV, Ward JW*. National Hepatitis Elimination Profiles: Progress towards HBV and HCV elimination in five European countries. EASL ILC 2022.
• Nunez V*, Hiebert L*, Nassar I-Y*, Ward JW*. National Hepatitis Elimination Profiles: Progress towards HBV and HCV elimination in the Americas. EASL Elimination Summit 2022.

HBV

Commentaries & Book Chapters

• OA Lesi and Ward JW*. Paving the way towards hepatitis B virus-free generations in Africa. Lancet Global Health.
• Ward JW*. Hepatitis B Vaccines In JH Kao ed. “Hepatitis B Virus and Liver Disease” Springer Nature Singapore, pgs 169-203.

Research Studies

• Brubaker SD, Ward JW*, Hiebert L*, Morgan RL. Developing an Evidence Base for the Delivery of Hepatitis B Virus Birth Dose Vaccination: An Evidence Map and Critical Appraisal of Systematic Reviews and Guidelines. Clinical Liver Disease.
• Wong RJ, Brosgart CL, Welch S, Block T, Chen M, Cohen C, Kim WR, Kowdley KB, Lok AS, Tsai N, Ward JW*, Wong SS, Gish RG. An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States. Hepatology.

HCV

Commentaries & Book Chapters

• Feld J and Ward JW*. Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020. Hepatology Communications.

Research Studies

• Boeke C, Hiebert L*, Waked I, Tsertsvadze T, Sharvadze L, Butsashvili M, Zakalshvili M, Naing W, Gupta N*, Kateera F, McClure C, Ward JW*, Ramers CB.Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries. Clinical Infectious Diseases.
• Lazarus, J. V., Picchio, C. A., Guy, D., Aleman, S., James, C., Nava, F. A., Øvrehus, A., Turnes, J., Ward, J. W.*, & Ustianowski, A. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy. Clinics and Research in Hepatology and Gastroenterology. 

Abstracts

• Gupta N*, Hiebert L*, Njuguna H*, Armstrong A, Wester C, Ward JW*. Launching A Novel Strategy to Assess the Safety of Direct-Acting Antivirals in Pregnant Women: The Treatment in Pregnancy for Hepatitis C (TiP-HepC) Clinical Case Registry. IVHEM 2021

HBV and HCV

• Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy RK, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW*, Fontana RJ, AASLD COVID-19 Vaccine Working Group. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. Hepatology.

Research Studies

• Laury J*, Hiebert L*, Ward JW*. Impact of COVID-19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers. Clinical Liver Disease.

Abstracts

• Njuguna H*, Hiebert L*, Jacques-Carroll L*, Gupta N*, Ward JW*. Key Gaps in National Strategic Plans for Global Hepatitis Elimination: Findings and Recommendations from a Systematic Review. AASLD 2021.

HBV

Abstracts

• Obiekwe R*, Hiebert L*, Sheena B, Direc M, Ward JW*. Country and WHO Regional Trends for Hepatitis B Virus (HBV) Mortality, 1990-2019: An analysis of the Global Burden of Disease (GBD) Study. AASLD 2020.
• Ward JW*, Hiebert L*, Sheena B, Dirac M. Global and regional burden of hepatitis B virus (HBV) mortality and disability-adjusted life years (DALYs), 2015-2019: an analysis of the Global Burden of Disease Study 2019. APASL 2020.

HCV

Commentaries & Book Chapters

• Ward JW*. The Nobel Prize for discovery of HCV is a call to end hepatitis. Lancet.

• Ward JW*, Hinman AR, Alter HJ. Time for the elimination of hepatitis C virus as a global health threat. In Arias IM, Wolkoff AW, Boyer JL, Shafritz DA, Fausto N, Alter HJ,  Cohen DE eds. The Liver: Biology and Pathobiology. 6th edition, West Sussex UK, John Wiley and sons Ltd; pgs 935-952

Research Studies

• Lazarus JV, Picchio CA, Guy D, Aleman S, James C, Nava FA, Øverhus A, Turnes J, Ward JW*, Ustianowski A.Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy. Clinics and Research in Hepatology and Gastroenterology.
• Mera J, Williams MB, Essez W, McGew KM, Boeckman L, Gahn D, Miller A, Durham D, Fox J, David C, Ritter T, Jones S, Bouse S, Galvani A, Ward JW*, Drevets DA, Carabin H. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation. JAMA Network Open.
• Ly KN, Miniño AM, Liu SJ, Roberts H, Hughes EM, Ward JW*, Jiles RB. Deaths Associated With Hepatitis C Virus Infection Among Residents in 50 States and the District of Columbia, 2016-2017. Clinical Infectious Diseases.

Abstracts

• Ramers CR, Hiebert L*, Boeke CE, Waked I, Tsertsvadze T, Sharvadze L, Butsashvili M, Zakalashvili M, Naing W, Gupta N*, Kateera F, Ward JW*. Retreatment for HCV: Preliminary results from a retrospective analysis of pooled national program data across low- and middle-income countries. AASLD 2020.
• Adams A*, Hiebert L*, Sheena B, Dirac M, Ward JW*. Country and WHO Regional Trends for Hepatitis C Virus (HCV) Mortality, 1990-2019: An Analysis of the Global Burden of Disease (GBD) Study. AASLD 2020.
• Hiebert L*, Sheena B, Dirac M, Ward JW*. Global and regional burden of hepatitis C virus (HCV) mortality and disability-adjust life years (DALYs), 2015-2019: an analysis of the Global Burden of Disease Study 2019. APASL 2020.

HBV and HCV

Commentaries & Book Chapters

• Lau G and Ward JW*. Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic. Clinical Liver Disease.
• Ward JW* and del Rio C. The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief. Clinical Liver Disease.
• SA Rasmussen, Ward JW*, Goodman RA Protecting the Editorial Independence of the CDC From Politics. JAMA.

HCV

Research Studies

• Hofmeister MG., Rosenthal EM, Barker LK, Rosenberg ES, Barranco MA, Hall EW, Edlin BR, Mermin J, Ward JW*, & Ryerson AB. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016. Hepatology.
• Eckman MH, Ward JW*, & Sherman KE. Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens. Clinical Gastroenterology and Hepatology: the official clinical practice journal of the American Gastroenterological Association.

HBV and HCV

Commentaries & Book Chapters

• Ward JW*. Launch of the Coalition for Global Hepatitis Elimination: a recommendation of the Lancet Gastroenterology & Hepatology Commission. Lancet Gastro Hep.
• Ward JW* and Himan A. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats. Gastroenterology.
• Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O, Sypsa V, Morgan T, Gamkrelidze A, Mukabatsinda C, Deuffic-Burban S, Ninburg M, Feld J, Hellard M, & Ward JW*.  The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals. Journal of Virus Eradication, 5(1), 60–66.
• Fix, O. K., Blumberg, E. A., Chang, K. M., Chu, J., Chung, R. T., Goacher, E. K., Hameed, B., Kaul, D. R., Kulik, L. M., Kwok, R. M., McGuire, B. M., Mulligan, D. C., Price, J. C., Reau, N. S., Reddy, K. R., Reynolds, A., Rosen, H. R., Russo, M. W., Schilsky, M. L., Verna, E. C., Ward, J. W.*, Fontana, J. Robert, AASLD COVID‐19 Vaccine Working Group. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. AASLD Hepatology.

Research Studies

• Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou J, Howell J, Jia J, Kravchenko N, Lazarus JV, Lemoine M, Lesi OA, Maistat L, McMahon BJ, Razavi H, Roberts T, Simmons B, Sonderup MW, Spearman CW, Taylor BE, Thomas DL, Waked I, Ward JW,* Wiktor SZ; Lancet Gastroenterology & Hepatology Commissioners. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology & Hepatology.